| Dr Jennifer Lynn Shoenfelt, MD | |
|
4075 Old Western Row Rd, Mason, OH 45040-3104 | |
| (513) 536-0644 | |
| (513) 536-0619 |
| Full Name | Dr Jennifer Lynn Shoenfelt |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 21 Years |
| Location | 4075 Old Western Row Rd, Mason, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659562965 | NPI | - | NPPES |
| 2844613 | Medicaid | OH | |
| SH7387391 | Other | OH | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 090873 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mccd Fl Psychiatry Services Pa | 4880064070 | 206 |
News Archive
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.
› Verified 7 days ago
| Entity Name | Psychological & Behavioral Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811915713 PECOS PAC ID: 0446243760 Enrollment ID: O20040405000363 |
News Archive
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.
› Verified 7 days ago
| Entity Name | Mccd Psychiatry Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033750823 PECOS PAC ID: 4082049036 Enrollment ID: O20220324002861 |
News Archive
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.
› Verified 7 days ago
| Entity Name | Mccd Fl Psychiatry Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659003457 PECOS PAC ID: 4880064070 Enrollment ID: O20230227000468 |
News Archive
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Lynn Shoenfelt, MD 4075 Old Western Row Rd, Mason, OH 45040-3104 Ph: (513) 536-0644 | Dr Jennifer Lynn Shoenfelt, MD 4075 Old Western Row Rd, Mason, OH 45040-3104 Ph: (513) 536-0644 |
News Archive
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.
› Verified 7 days ago
Dr. Nikhilesh Raju, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-4673 | |
Dr. Anurag Tewari, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8118 Corporate Way Ste 212, Mason, OH 45040 Phone: 484-351-8459 Fax: 484-351-8810 | |
Shana Feibel, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-4673 | |
William Paul Hartmann Iii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-0600 Fax: 513-536-0609 | |
Lorene Walter, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-4673 Fax: 513-536-0609 | |
Brian Patrick Dowling, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-0628 Fax: 513-536-0619 | |
Dr. Danielle J Johnson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4075 Old Western Row Rd, Mason, OH 45040 Phone: 513-536-4673 |